TuHURA BIOSCIENCES, INC./NV Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
TuHURA BIOSCIENCES, INC./NV (HURA) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$16.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$9.22M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$7.54M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$6.76M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$7.10M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$30.05M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$21.68M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$8.32M.
- TuHURA BIOSCIENCES, INC./NV net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$29.32M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 36 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$16.76M 10-Q · filed 2026-08-14 | -$23.52M derived: sum of 3 quarters · filed 2026-08-14 | -$30.62M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$7.54M 10-Q · filed 2026-05-15 | -$14.30M derived: sum of 2 quarters · filed 2026-05-15 | -$21.40M derived: sum of 3 quarters · filed 2026-05-15 | -$30.92M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$6.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$13.86M derived: sum of 2 quarters · filed 2026-03-31 | -$23.39M derived: sum of 3 quarters · filed 2026-08-14 | -$30.05M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$7.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$16.63M derived: sum of 2 quarters · filed 2026-08-14 | -$23.29M 10-Q · filed 2025-11-14 | -$29.29M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$9.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$16.19M 10-Q · filed 2026-08-14 | -$22.18M derived: sum of 3 quarters · filed 2026-08-14 | -$24.35M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$6.66M 10-Q · filed 2026-05-15 | -$12.66M derived: sum of 2 quarters · filed 2026-05-15 | -$14.82M derived: sum of 3 quarters · filed 2026-05-15 | -$20.09M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.16M derived: sum of 2 quarters · filed 2026-03-31 | -$13.42M derived: sum of 3 quarters · filed 2026-03-31 | -$21.68M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$2.16M 10-Q · filed 2024-11-14 | -$7.43M derived: sum of 2 quarters · filed 2025-08-14 | -$15.69M 10-Q · filed 2025-11-14 | -$13.29M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-06-30 | -$5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$10.11M 10-Q · filed 2025-08-14 | -$11.13M derived: sum of 3 quarters · filed 2025-08-14 | -$8.32M 10-K · filed 2024-10-07 | |||
| 2024-03-31 | -$4.84M 10-Q · filed 2025-05-15 | -$2.01M 10-Q · filed 2024-05-14 | -$5.87M derived: sum of 2 quarters · filed 2025-05-15 | -$6.00M 10-Q · filed 2024-05-14 | -$12.16M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$1.02M 10-Q · filed 2024-05-14 | -$3.98M 10-Q · filed 2024-02-14 | -$7.32M derived: sum of 3 quarters · filed 2024-11-14 | -$29.32M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$2.96M 10-Q · filed 2024-11-14 | -$6.30M derived: sum of 2 quarters · filed 2024-11-14 | -$9.56M derived: sum of 3 quarters · filed 2024-11-14 | -$13.02M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | -$6.60M derived: sum of 2 quarters · filed 2024-10-07 | -$10.05M derived: sum of 3 quarters · filed 2024-10-07 | -$14.65M 10-K · filed 2024-10-07 | |||
| 2023-03-31 | -$3.26M 10-Q · filed 2024-05-14 | -$6.72M derived: sum of 2 quarters · filed 2024-05-14 | -$11.31M 10-Q · filed 2024-05-14 | -$16.76M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$3.45M 10-Q · filed 2024-05-14 | -$8.05M 10-Q · filed 2024-02-14 | -$13.50M derived: sum of 3 quarters · filed 2024-05-14 | -$18.85M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-09-30 | -$4.60M 10-Q · filed 2024-05-14 | -$10.04M derived: sum of 2 quarters · filed 2024-05-14 | -$15.40M derived: sum of 3 quarters · filed 2024-05-14 | -$21.29M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-06-30 | -$5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-18 | -$10.80M derived: sum of 2 quarters · filed 2023-09-18 | -$16.70M derived: sum of 3 quarters · filed 2023-09-18 | -$22.66M 10-K · filed 2023-09-18 | |||
| 2022-03-31 | -$5.36M 10-Q · filed 2023-05-11 | -$11.25M derived: sum of 2 quarters · filed 2023-05-11 | -$17.21M 10-Q · filed 2023-05-11 | -$23.95M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$5.89M 10-Q · filed 2023-05-11 | -$11.86M 10-Q · filed 2023-02-14 | -$18.59M derived: sum of 3 quarters · filed 2023-05-11 | -$25.23M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-09-30 | -$5.97M 10-Q · filed 2023-05-11 | -$12.70M derived: sum of 2 quarters · filed 2023-05-11 | -$19.33M derived: sum of 3 quarters · filed 2023-05-11 | -$24.75M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-06-30 | -$6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$13.37M derived: sum of 2 quarters · filed 2022-09-27 | -$18.78M derived: sum of 3 quarters · filed 2022-09-27 | -$38.30M 10-K · filed 2022-09-27 | |||
| 2021-03-31 | -$6.63M 10-Q · filed 2022-05-13 | -$12.05M derived: sum of 2 quarters · filed 2022-05-13 | -$31.57M 10-Q · filed 2022-05-13 | -$35.39M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$5.41M 10-Q · filed 2022-05-13 | -$24.93M 10-Q · filed 2022-02-11 | -$28.75M derived: sum of 3 quarters · filed 2022-05-13 | -$30.71M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-09-30 | -$19.52M 10-Q · filed 2022-05-13 | -$23.34M derived: sum of 2 quarters · filed 2022-05-13 | -$25.30M derived: sum of 3 quarters · filed 2022-05-13 | -$27.04M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-06-30 | -$3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | -$5.78M derived: sum of 2 quarters · filed 2021-09-28 | -$7.52M derived: sum of 3 quarters · filed 2021-09-28 | -$9.13M 10-K · filed 2021-09-28 | -$9.13M 10-K · filed 2020-09-18 | ||
| 2020-03-31 | -$1.96M 10-Q · filed 2021-05-13 | -$1.96M 10-Q · filed 2020-05-13 | -$3.70M derived: sum of 2 quarters · filed 2021-05-13 | -$5.30M 10-Q · filed 2021-05-13 | -$7.89M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$1.74M 10-Q · filed 2021-05-13 | -$1.74M 10-Q · filed 2020-02-13 | -$3.35M 10-Q · filed 2021-02-12 | -$5.93M derived: sum of 3 quarters · filed 2021-05-13 | -$7.59M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-09-30 | -$1.61M 10-Q · filed 2021-05-13 | -$1.61M 10-Q · filed 2019-11-13 | -$4.19M derived: sum of 2 quarters · filed 2021-05-13 | -$5.85M derived: sum of 3 quarters · filed 2021-05-13 | -$7.66M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-06-30 | -$2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | -$4.25M derived: sum of 2 quarters · filed 2020-09-18 | -$6.06M derived: sum of 3 quarters · filed 2020-09-18 | -$8.05M 10-K · filed 2020-09-18 | |||
| 2019-03-31 | -$1.66M 10-Q · filed 2020-05-13 | -$3.47M derived: sum of 2 quarters · filed 2020-05-13 | -$5.47M 10-Q · filed 2019-05-14 | -$7.84M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$1.81M 10-Q · filed 2020-05-13 | -$3.80M 10-Q · filed 2019-02-11 | -$6.18M derived: sum of 3 quarters · filed 2020-05-13 | -$9.11M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-09-30 | -$1.99M 10-Q · filed 2020-05-13 | -$4.37M derived: sum of 2 quarters · filed 2020-05-13 | -$7.30M derived: sum of 3 quarters · filed 2020-05-13 | -$10.46M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-06-30 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | -$5.31M derived: sum of 2 quarters · filed 2019-09-09 | -$8.47M derived: sum of 3 quarters · filed 2019-09-09 | -$11.14M 10-K · filed 2019-09-09 | |||
| 2018-03-31 | -$2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$6.09M derived: sum of 2 quarters · filed 2019-05-14 | -$8.76M 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | -$3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | -$5.83M 10-Q · filed 2019-02-11 | |||||
| 2017-09-30 | -$2.67M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | -$8.08M 8-K · filed 2019-06-03 | ||||||
| 2012-06-30 | -$982.00 10-K/A · filed 2012-12-20 | -$18.89K 10-K/A · filed 2012-12-20 | -$57.69K 10-K/A · filed 2012-12-20 | ||||
| 2011-06-30 | -$6.83K 10-K/A · filed 2012-12-20 | -$33.21K 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |